Webflow Homepage
Veterinarians
Services For
Canine lymphoma & Leukemia
Personalized Prediction Profile
AI-Driven Drug Response Predictions
(Flow Cytometry + PARR included)
Drug Response Predictions
NEW
Personalize anticancer drug treatment decisions with confidence
Immunoprofile
Get accurate diagnostic support from the start (Flow Cytometry + PARR)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Multidrug Sensitivity Genotyping (MDR1)
Identify MDR1 carrier status with ease
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
Services For
FELINE lymphoma & Leukemia
Immunoprofile
Get accurate diagnostic support from the start (PARR + Flow Cytometry)
Flow Cytometry
Accurately determine lymphoma or leukemia subtypes
PARR
Detect neoplastic B-cell or T-cell clones
Digital Cytology (Add-on)
Confirm lymphoma or leukemia with precision
for
veterinarians
Order Services via Vet Portal
Request Sample Reports
See what you will get when you order ImpriMed's services
Request Pricing
Become an ImpriMed Provider
Participate in Our Research
💖 Wall of Love: Customer Reviews
Veterinary Cancer Pioneers Podcast
Contact Us
Pet Parents
LEARN
How It Works
Dog Lymphoma 101
Cat Lymphoma 101
Blog
Content Library
Get Started
Find a Veterinary Oncologist
Talk to Your Veterinarian
Customer stories & Case Studies
ImpriMed Reviews
Discover what other pet parents are saying and how oncologists use ImpriMed's reports
Human Oncology
CRO
Company
Company
Our Science
About Us
Careers
Events
Press
Contact Us
Contact Us
Other Links
ImpriMed Korea
Pricing
Language
日本語 (Japanese)
English (International)
日本語 (Japanese)
English (International)
Find a Vet
Get Started
Press
Newsroom
Contact
press@imprimedicine.com
Follow
Download
Press Kit
Featured articles
TechCrunch
Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology
Read More →
USA Today
ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment
Read More →
International Business Times
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
Read More →
MedCity News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
Read More →
Latest Stories
Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
In the News
ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization
International Business Times
Learn More →
In the News
ImpriMed: A Breath of Fresh Air for Traditionally Onerous Cancer Treatment Journeys
Innovative Veterinary Care Journal
Learn More →
Press Releases
ImpriMed Celebrates the Milestone of 4,000 Dog Blood Cancer Patients
Business Insider
Learn More →
In the News
New AI Technology From ImpriMed Helps Improve Cancer Treatment Success Rates in Your Practice…and Fosters Better Relationships
Innovative Veterinary Care Journal
Learn More →
Scientific Publications
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma
npj Precision Oncology
Learn More →
Presentations
ImpriMed: AI-driven Personalized Medicine for Pet Cancer Care
Veterinary Cancer Society-Veterinary Society of Surgical Oncology Collaborative Conference 2023
Learn More →
Presentations
Reinventing precision medicine: from dogs to humans
Precision Medicine World Conference 2023
Learn More →
Presentations
Identification of Novel Predictive Biomarkers of Anticancer Drug Responses in Canine B-Cell Lymphoma Using Targeted NGS
Veterinary Cancer Society Annual Conference 2022
Learn More →
Presentations
ImpriMed Research Update
Veterinary Cancer Society Annual Conference 2022
Learn More →
In the News
The latest and greatest in canine oncology treatment
DVM360
Learn More →
Press Releases
ImpriMed Wins Place at the Mayo Clinic Platform_Accelerate Immersive Program
EIN Presswire
Learn More →
In the News
Get Rid of Your Cancer Treatment Frustrations
Innovative Veterinary Care Journal
Learn More →
In the News
Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator
MedCity News
Learn More →
In the News
Be sure to improve your cancer treatment outcomes
Innovative Veterinary Care Journal
Learn More →
Press Releases
40 Under 40 in Cancer Class of 2022 Recognizes Dr. Sungwon Lim, ImpriMed CEO & Co-Founder
EIN Presswire
Learn More →
In the News
Early leukemia and lymphoma remissions in cats and dogs
Innovative Veterinary Care Journal
Learn More →
In the News
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 3)
One Million by One Million
Learn More →
In the News
Thought Leaders in Artificial Intelligence: ImpriMed CEO Sungwon Lim (Part 2)
One Million by One Million
Learn More →
Previous
Next
